Validation of Progesterone [Bioanalytics]

posted by Compliance – India, 2013-09-10 12:13 (4668 d 06:39 ago) – Posting: # 11467
Views: 5,083

Dear All,

We are working on Progesterone and I have query related to the approach applied by the CRO while validating the method.

As per my understanding and methods from the various CRO, all have done the validation with stripped and un-stripped plasma for the endogenous molecule. However the CRO with whom we are dealing has validated the method by using female plasma and use only those plasma for the bulk spiking which has shown less or nil endogenous level of progesterone and done the validation as per routine practices/ process applied to routine molecule.

Is this approach is acceptable? however during study we are going to collect 2-3 pre dose sample for the base line correction.

The approach applied by the CRO is new for me and seeking your expert comment on this. Logically I am agree with their approach however only worried about how the regulatory take this.

Regards,

Compliance

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
173 visitors (0 registered, 173 guests [including 45 identified bots]).
Forum time: 18:53 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5